School of Pharmaceutical Sciences, Sun Yat-sen University , Guangzhou, Guangdong 510006, People's Republic of China.
J Nat Prod. 2014 Dec 26;77(12):2651-7. doi: 10.1021/np500528u. Epub 2014 Dec 12.
(±)-Torreyunlignans A-D (1a/1b-4a/4b), four pairs of new 8-9' linked neolignan enantiomers featuring a rare (E)-2-styryl-1,3-dioxane moiety, were isolated from the trunk of Torreya yunnanensis. The structures were determined by combined spectroscopic and chemical methods, and the absolute configurations were elucidated by ECD calculations. The compounds were screened by using tritium-labeled adenosine 3',5'-cyclic monophosphate ([(3)H]-cGMP) as a substrate for inhibitory affinities against phosphodiesterase-9A (PDE9A), which is a potential target for the treatment of diabetes and Alzheimer's disease. All of the enantiomers exhibited inhibition against PDE9A with IC50 values ranging from 5.6 to 15.0 μM. This is the first report of PDE9A inhibitors from nature.
(±)-Torreyunlignans A-D(1a/1b-4a/4b),四种新的 8-9' 连接型新木脂素对映异构体,具有罕见的(E)-2-苯乙烯基-1,3-二氧戊环部分,从云南榧的树干中分离得到。结构通过综合光谱和化学方法确定,绝对构型通过 ECD 计算阐明。这些化合物通过使用氚标记的腺苷 3',5'-环单磷酸([(3)H]-cGMP)作为对磷酸二酯酶-9A(PDE9A)的抑制亲和力的筛选,PDE9A 是治疗糖尿病和阿尔茨海默病的潜在靶点。所有对映异构体均表现出对 PDE9A 的抑制作用,IC50 值范围为 5.6 至 15.0 μM。这是首次从天然产物中报道 PDE9A 抑制剂。